- Home
- CODA vs BYSI Comparison
CODA vs BYSI Comparison
Compare CODA & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- BYSI
- Stock Information
- Founded
- CODA 1994
- BYSI 2010
- Country
- CODA United States
- BYSI United States
- Employees
- CODA N/A
- BYSI N/A
- Industry
- CODA Industrial Machinery/Components
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- BYSI Health Care
- Exchange
- CODA Nasdaq
- BYSI Nasdaq
- Market Cap
- CODA 85.8M
- BYSI 71.0M
- IPO Year
- CODA N/A
- BYSI 2017
- Fundamental
- Price
- CODA $7.93
- BYSI $2.03
- Analyst Decision
- CODA Strong Buy
- BYSI
- Analyst Count
- CODA 1
- BYSI 0
- Target Price
- CODA $11.00
- BYSI N/A
- AVG Volume (30 Days)
- CODA 58.5K
- BYSI 25.2K
- Earning Date
- CODA 09-15-2025
- BYSI 08-11-2025
- Dividend Yield
- CODA N/A
- BYSI N/A
- EPS Growth
- CODA 21.86
- BYSI N/A
- EPS
- CODA 0.30
- BYSI N/A
- Revenue
- CODA $22,758,966.00
- BYSI N/A
- Revenue This Year
- CODA $30.82
- BYSI N/A
- Revenue Next Year
- CODA $20.84
- BYSI N/A
- P/E Ratio
- CODA $25.09
- BYSI N/A
- Revenue Growth
- CODA 24.78
- BYSI N/A
- 52 Week Low
- CODA $5.76
- BYSI $0.98
- 52 Week High
- CODA $9.89
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- CODA 51.98
- BYSI 44.54
- Support Level
- CODA $7.50
- BYSI $1.87
- Resistance Level
- CODA $8.01
- BYSI $2.13
- Average True Range (ATR)
- CODA 0.47
- BYSI 0.15
- MACD
- CODA -0.08
- BYSI -0.02
- Stochastic Oscillator
- CODA 50.18
- BYSI 43.10
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.